LISCure Biosciences

Developer of bacteria-mediated immunotherapy designed to treat tumors as well as cancer. The company's immunotherapy is used by combining drugs, consisting of seven pipelines of medicine and two pipel...

Healthcare

Seongnam-si, South Korea

Founded 2018

28 employees

Website

Valuation

Share Price

N/A

Total Raised

$47.5M

Last Round

N/A

Investors

+18 other investors

View all 18 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock LISCure Biosciences's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required